The difficulties of classifying renal disease in HIV-infected patients

HIV Medicine

Volumn 12, Issue 1, 2011, Pages 1-3

  Mocroft, A ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CREATININE;

CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FAILURE; PRIORITY JOURNAL;

HIV INFECTIONS; HUMANS; KIDNEY DISEASES;

EID: 78650127794     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2010.00854.x     Document Type: Editorial

References (37)

1. Tordato F, Cozzi Lepri A, Cicconi P et al. for the ICONA Foundation Study Group. Evaluation of glomerular filtration rate in HIV-1-infected patients before and after combined antiretroviral therapy exposure. HIV Med 2011; 12: 4-13.
2. Mocroft A, Vella S, Benfield TL et al. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet 1998; 352: 1725-1730.
3. Phillips AN, Neaton J, Lundgren JD. The role of HIV in serious diseases other than AIDS. AIDS 2008; 22: 2409-2418.
4. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
5. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
6. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
7. Lamb EJ, Wood J, Stowe HJ et al. Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients. Ann Clin Biochem 2005; 42 (Part 1): 11-18.
8. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920-929.
9. Ravasi G, Lauriola M, Tinelli C, Brandolini M, Uglietti A, Maserati R. Comparison of glomerular filtration rate estimates vs. 24-h creatinine clearance in HIV-positive patients. HIV Med 2009; 10: 219-228.
10. Barraclough K, Er L, Ng F et al. A comparison of the predictive performance of different methods of kidney function estimation in a well-characterized HIV-infected population. Nephron Clin Pract 2009; 111: c39-c48.
11. Verhave JC, Fesler P, Ribstein J, Du CG, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005; 46: 233-241.
12. Stohr W, Walker AS, Munderi P et al. Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and modification of diet in renal disease formulae. Antivir Ther 2008; 13: 761-770.
13. Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585.
14. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1-S266.
15. Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol 2008; 19: 844-846.
16. Stevens LA, Manzi J, Levey AS et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis 2007; 50: 21-35.
17. Mocroft A, Kirk O, Reiss P et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 2010, in press.
18. Reid A, Stohr W, Walker AS et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis 2008; 46: 1271-1281.
19. Bansi L, Hughes A, Bhagani S et al. Clinical epidemiology of HIV-associated end-stage renal failure in the UK. AIDS 2009; 23: 2517-2521.
20. Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med 2009; 10: 343-350.
21. Campbell LJ, Ibrahim F, Fisher M et al. Spectrum of chronic kidney disease in HIV-infected patients. HIV Med 2009; 10: 329-336.
22. Fischer MJ, Wyatt CM, Gordon K et al. Hepatitis C and the risk of kidney disease and mortality in veterans with HIV. J Acquir Immune Defic Syndr 2010; 53: 222-226.
23. George E, Lucas GM, Nadkarni GN et al. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS 2010; 24: 387-394.
24. Lucas GM, Lau B, Atta MG et al. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis 2008; 197: 1548-1557.
25. Mocroft A, Kirk O, Gatell J et al. Chronic renal failure among HIV-1-infected patients. AIDS 2007; 21: 1119-1127.
26. Lucas GM, Mehta SH, Atta MG et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21: 2435-2443.
27. Reid A, Stuhr W, Walker AS et al. Glomerular dysfunction and associated risk factors through four years following initiation of ART in adults with HIV infection in Africa in the DART trial. 5th International AIDS Society Conference on HIV Pathogenesis and Treatment. Cape Town, South Africa, July 2009 [Abstract TUPEB184].
28. Choi AI, Shlipak MG, Hunt PW, Martin JN, Deeks SG. HIV-infected persons continue to lose kidney function despite successful antiretroviral therapy. AIDS 2009; 23: 2143-2149.
29. Gallant JE, Moore RD. Renal function with use of a tenofovir-containing initial antiretroviral regimen. AIDS 2009; 23: 1971-1975.
30. Goicoechea M, Liu S, Best B et al. Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy. J Infect Dis 2008; 197: 102-108.
31. Horberg M, Tang B, Towner W et al. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr 2010; 53: 62-69.
32. Longenecker CT, Scherzer R, Bacchetti P et al. HIV viremia and changes in kidney function. AIDS 2009; 23: 1089-1096.
33. Antoniou T, Raboud J, Chirhin S et al. Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study. HIV Med 2005; 6: 284-290.
34. Izzedine H, Sene D, Cacoub P et al. Kidney diseases in HIV/HCV-co-infected patients. AIDS 2009; 23: 1219-1226.
35. Cosgrove CJ, Bu-Alfa AK, Perazella MA. Observations on HIV-associated renal disease in the era of highly active antiretroviral therapy. Am J Med Sci 2002; 323: 102-106.
36. Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci 2008; 335: 89-94.
37. Justice AC, McGinnis KA, Skanderson M et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med 2010; 11: 143-151.